Evidence map›Paper›PMID 38862466›Full record

ArticleNature communications2024

DOT: a flexible multi-objective optimization framework for transferring features across single-cell and spatial omics.

Arezou Rahimi, Luis A Vale-Silva, Maria Fälth Savitski, Jovan Tanevski, Julio Saez-Rodriguez

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arezou RahimiInstitute for Computational Biomedicine, Heidelberg University & Heidelberg University Hospital, Heidelberg, Germany.
Luis A Vale-SilvaCellzome GmbH, GlaxoSmithKline, Heidelberg, Germany.ORCID 0000-0002-9658-5335
Maria Fälth SavitskiCellzome GmbH, GlaxoSmithKline, Heidelberg, Germany.
Jovan Tanevski *Institute for Computational Biomedicine, Heidelberg University & Heidelberg University Hospital, Heidelberg, Germany. jovan.tanevski@uni-heidelberg.de.ORCID 0000-0001-7177-1003
Julio Saez-Rodriguez *Institute for Computational Biomedicine, Heidelberg University & Heidelberg University Hospital, Heidelberg, Germany. pub.saez@uni-heidelberg.de.ORCID 0000-0002-8552-8976

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell transcriptomics and spatially-resolved imaging/sequencing technologies have revolutionized biomedical research. However, they suffer from lack of spatial information and a trade-off of resolution and gene coverage, respectively. We propose DOT, a multi-objective optimization framework for transferring cellular features across these data modalities, thus integrating their complementary information. DOT uses genes beyond those common to the data modalities, exploits the local spatial context, transfers spatial features beyond cell-type information, and infers absolute/relative abundance of cell populations at tissue locations. Thus, DOT bridges single-cell transcriptomics data with both high- and low-resolution spatially-resolved data. Moreover, DOT combines practical aspects related to cell composition, heterogeneity, technical effects, and integration of prior knowledge. Our fast implementation based on the Frank-Wolfe algorithm achieves state-of-the-art or improved performance in localizing cell features in high- and low-resolution spatial data and estimating the expression of unmeasured genes in low-coverage spatial data.

Indexed as

AlgorithmsSingle-Cell AnalysisAnimalsComputational BiologyGene Expression ProfilingHumansTranscriptome

Identifiers

PMID38862466
PMCPMC11167014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.